Targeted Toxicities: Protocols for Monitoring the Adverse Events of Targeted Therapies Used in the Treatment of Non-Small Cell Lung Cancer

Targeted therapies have revolutionized the treatment for many patients with non-small cell lung cancer (NSCLC). Multiple new oral targeted therapies have been approved in the last decade; however, their overall efficacy may be reduced by poor adherence, treatment interruptions, or dose reductions du...

Descripción completa

Detalles Bibliográficos
Autores principales: Hines, Jacobi B., Bowar, Benjamin, Levine, Emma, Esposito, Alessandra, Garassino, Marina C., Bestvina, Christine M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253830/
https://www.ncbi.nlm.nih.gov/pubmed/37298380
http://dx.doi.org/10.3390/ijms24119429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253830/
https://www.ncbi.nlm.nih.gov/pubmed/37298380
http://dx.doi.org/10.3390/ijms24119429

Ejemplares similares